LEADER 01370nam  2200397 a 450 
001 9910693197203321
005 20041129110827.0
035   $a(CKB)5470000002359538
035   $a(OCoLC)57070433
035 9 $aocm57070433
035   $a(OCoLC)995470000002359538
035   $a(EXLCZ)995470000002359538
100   $a20041129d2004      ua             0
101 0 $aeng
135   $aurmn||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare$b[electronic resource] $eappropriate dispensing fee needed for suppliers of inhalation therapy drugs : report to congressional committees
210  1$a[Washington, D.C.] :$cU.S. Government Accountability Office,$d[2004]
300   $aTitle from title screen (viewed on Nov. 23, 2004).
300   $a"October 2004."
300   $aPaper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
300   $a"GAO-05-72."
320   $aIncludes bibliographical references.
517   $aMedicare 
606   $aRespiratory therapy$zUnited States$xCosts$xEvaluation
606   $aMedicare
615  0$aRespiratory therapy$xCosts$xEvaluation.
615  0$aMedicare.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910693197203321
996   $aMedicare$92879855
997   $aUNINA